NRXS
Price
$2.37
Change
-$0.05 (-2.07%)
Updated
Apr 24, 02:10 PM (EDT)
Capitalization
14.07M
27 days until earnings call
VTYX
Price
$1.22
Change
+$0.06 (+5.17%)
Updated
Apr 24, 02:54 PM (EDT)
Capitalization
83.93M
14 days until earnings call
Ad is loading...

NRXS vs VTYX

Header iconNRXS vs VTYX Comparison
Open Charts NRXS vs VTYXBanner chart's image
Neuraxis
Price$2.37
Change-$0.05 (-2.07%)
Volume$110
Capitalization14.07M
Ventyx Biosciences
Price$1.22
Change+$0.06 (+5.17%)
Volume$5.23K
Capitalization83.93M
NRXS vs VTYX Comparison Chart
Loading...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXS vs. VTYX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a StrongBuy and VTYX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (NRXS: $2.42 vs. VTYX: $1.16)
Brand notoriety: NRXS and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 236% vs. VTYX: 83%
Market capitalization -- NRXS: $14.07M vs. VTYX: $83.93M
NRXS [@Biotechnology] is valued at $14.07M. VTYX’s [@Biotechnology] market capitalization is $83.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than NRXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 4 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • NRXS’s TA Score: 4 bullish, 5 bearish.
  • VTYX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VTYX is a better buy in the short-term than NRXS.

Price Growth

NRXS (@Biotechnology) experienced а +49.19% price change this week, while VTYX (@Biotechnology) price change was +9.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

NRXS is expected to report earnings on May 21, 2025.

VTYX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($83.9M) has a higher market cap than NRXS($14.1M). NRXS YTD gains are higher at: 2.843 vs. VTYX (-47.032). NRXS has higher annual earnings (EBITDA): -8.02M vs. VTYX (-147.1M). VTYX has more cash in the bank: 217M vs. NRXS (261K). NRXS has less debt than VTYX: NRXS (477K) vs VTYX (10.8M). NRXS has higher revenues than VTYX: NRXS (2.46M) vs VTYX (0).
NRXSVTYXNRXS / VTYX
Capitalization14.1M83.9M17%
EBITDA-8.02M-147.1M5%
Gain YTD2.843-47.032-6%
P/E RatioN/AN/A-
Revenue2.46M0-
Total Cash261K217M0%
Total Debt477K10.8M4%
TECHNICAL ANALYSIS
Technical Analysis
NRXSVTYX
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 18 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EOLS11.230.77
+7.36%
Evolus
ENOV33.791.17
+3.59%
Enovis Corp
EMX2.210.03
+1.38%
EMX Royalty Corp
PPL36.240.03
+0.08%
PPL Corp
MEIP1.98N/A
N/A
MEI Pharma

NRXS and

Correlation & Price change

A.I.dvisor tells us that NRXS and RZLT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRXS and RZLT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+23.94%
RZLT - NRXS
25%
Poorly correlated
+27.65%
NGNE - NRXS
24%
Poorly correlated
+11.79%
PLUR - NRXS
23%
Poorly correlated
+40.83%
TCRT - NRXS
23%
Poorly correlated
+2.92%
ESLA - NRXS
22%
Poorly correlated
+16.10%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-1.69%
KYMR - VTYX
41%
Loosely correlated
+6.56%
ADCT - VTYX
40%
Loosely correlated
+4.88%
IMNM - VTYX
40%
Loosely correlated
+3.54%
FDMT - VTYX
40%
Loosely correlated
+0.29%
BHVN - VTYX
40%
Loosely correlated
+1.28%
More